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Gangliosides, which are complex glycospingolipids, have
been implicated in the receptor-mediated effects of numer-
ous agents, including enterotoxins and glycoprotein
hormones (6). The nonpolar portion of these compounds,
consisting of an N-acyl fatty acid derivative of sphingo-
sine, is believed to serve as an anchor in the plasma
membrane, whereas the carbohydrate moiety, which is
exposed to the extracellular space, is believed to be respon-
sible for receptor specificity. One of the more fully charac-
terized ganglioside-protein interactions is that between
ganglioside GMI (galactosy-N-acetylgalactosaminyl-[N-
acetyl-neuraminyl]-galactosylglucosylceramide) and the
enterotoxin of Vibrio cholerae that is responsible for the
clinical characteristics of cholera (3). Choleratoxin or
choleragen (CT) is composed of two types of subunits held
together by noncovalent interactions. The A component,
which is believed to be composed of two polypeptide chains
joined by a single disulfide bond, activates adenylate
cyclase through a NAD-dependent ADP-ribosylation
reaction (9). The B component, of which there are 4-6
molecules in the intact toxin, is responsible for the specific
interaction between the toxin and GM, (3, 10). Thus the
initial event in the action of CT on cells is the binding of
the B component to the oligosaccharide 'moiety of GM,.
The remaining events are not known with certainty; the Al
subunit is currently believed to be inserted into the
membrane bilayer (presumably after reduction of the
disulfide bond that links it to A2) and ultimately ADP-
ribosylates a regulatory protein in the cyclase system.
The effects of a heat-labile enterotoxin of Escherichia
coli (LT) on cells resemble in many ways those of CT. LT
also appears to be structurally similar to CT in that it
contains two types of subunits with molecular weights
similar to those found for CT (1 1). The catalytic A subunit
of LT is however believed to be a single polypeptide chain
(5, 7) rather than a disulfide linked dimer as found for CT
(1, 2, 3). In view of the similar structure and mode of
action of these two enterotoxins we have investigated the
interaction between LT and GM,.
RESULTS AND DISCUSSION
Incorporation of purified GM, into GM,-deficient C6
glioma cells increased the subsequent binding of '251I-LT or
'251I-CT. This increase was blocked for both toxins by prior
treatment of GM,-treated cells with unlabeled CT. Treat-
ment of the cells with GDla (N-acetylneuraminylgalac-
tosyl-N-acetylgalatosaminyl-[N-acetylneuraminyl]-galac-
tosylglucosylceramide, GM2 (N-acetylgalactosaminyl-
[N-acetylneuraminyl]-galactosylglucosylceramide) or
GD b (galactosyl-N-acetylgalactosaminyl- [N-acetyl-
neuraminyl-N-acetylneuraminyl] -galactosylglucosyl-
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ceramide) had no effect on '25I-LT or '25I-CT interaction
with the cells.
Interpretation of data concerning interactions between
LT and isolated gangliosides is complicated by ganglioside
self-association and possible nonspecific hydrophobic
interactions between the toxin and the ceramide moiety of
gangliosides. These complications can be avoided by use of
the isolated oligosaccharide moiety in binding studies.
GM,-oligosaccharide caused a concentration-dependent
"blue shift" in the tryptophanyl fluorescence spectrum of
LT and the corresponding isolated B subunit (LTB). The
wavelength of maximum fluorescence shifted to 328 nm at
saturating oligosaccharide concentrations (- 5:1 oligosac-
charide:toxin) which is similar to that observed previously
for CT and CTB (4). Increases in fluorescence intensity at
328 nm on interaction of LT or LTB with GM,-oligosac-
charide paralleled closely that observed upon interaction
of CT (or CTB) with GM,-oligosaccharide. The oligosac-
charides of gangliosides GM3 and GDla did not cause
changes in the fluorescence spectrum of LT or CT.
LT possesses ADP-ribosyltransferase activity; guanid-
ine compounds and proteins have been shown to serve as
ADP-ribose acceptors (3). Treatment of purified LT with
trypsin resulted in a 200% increase in ADP-ribosyltrans-
ferase activity in cell-free systems; the final specific activ-
ity was similar to that of untreated CT (8). Presumably
trypsin acts on the intact A subunit of LT, generating a
fragment with ADP-ribosyltransferase activity similar to
the Al subunit of CT. These results are consistent with the
hypothesis that LT has a single, unnicked polypeptide
chain which is relatively inactive without protease treat-
ment; it should be noted, however, that a reducing agent is
still required for full LT activity.
In summary, these combined results are consistent with
a mode of action similar for CT and LT. Specificity for
action on target cells resides in the B subunits of LT and
CT and the oligosaccharide moiety of GM,, which appears
to serve as the cell surface receptor for both toxins. The
major difference between the two enterotoxins is that
because of the presence of an unnicked A subunit in LT,
trypsin treatment is required for full expression of enzy-
matic activity. This may account for differences in the
effects of LT and CT on target cells.
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